In addition, PGC-1α knockdown decreased ATP production, reduced actin cytoskeleton remodeling, lowered anchorage-independent survival, and decreased intra-/extravasation, which are all checkpoints that prevent metastasis in MDA-MB-231 breast cancer and B16F10 melanoma cells [93]. This evidence concerns the gene PPARGC1A and breast carcinoma.